Which age ranges were primarily tested during polivy's clinical studies?

Which age groups were included in Polivy’s clinical studies?

Polivy (polatuzumab vedotin) was primarily tested in adult patients. The clinical studies that support its use enrolled patients in these adult age ranges: 18 to 80 years old, and 65 years and older were specifically represented in the safety and efficacy population. [1][2]

Did Polivy trials include elderly patients?

Yes. Subsets of the trial populations included older adults, including patients 65 years and older, as well as patients up to age 80. [1][2]

Were there pediatric age ranges tested?

The provided study information covers adult age ranges (from 18 years up to about 80 years). It does not describe pediatric testing within the stated age ranges. [1][2]

Sources:
1. https://www.accessdata.fda.gov/drugsatfdadocs/label/2024/761124s032lbl.pdf
2. https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/761124s000lbl.pdf